A quantitative SVM approach potentially improves the accuracy of magnetic resonance spectroscopy in the preoperative evaluation of the grades of diffuse gliomas

Abstrct Objectives To investigate the association between proton magnetic resonance spectroscopy (1H-MRS) metabolic features and the grade of gliomas, and to establish a machine-learning model to predict the glioma grade. Methods This study included 112 glioma patients who were divided into the training (n = 74) and validation (n = 38) sets based on the time of hospitalization. Twenty-six metabolic features were extracted from the preoperative 1H-MRS image. The Student's t-test was conducted to screen for differentially expressed features between low- and high-grade gliomas (WHO grades II and III/IV, respectively). Next, the minimum Redundancy Maximum Relevance (mRMR) algorithm was performed to further select features for a support vector machine (SVM) classifier building. Performance of the predictive model was evaluated both in the training and validation sets using ROC curve analysis. Results Among the extracted 1H-MRS metabolic features, thirteen features were differentially expressed. Four features were further selected as grade-predictive imaging signatures using the mRMR algorithm. The predictive performance of the machine-learning model measured by the AUC was 0.825 and 0.820 in the training and validation sets, respectively. This was better than the predictive performances of individual metabolic features, the best of which was 0.812. Conclusions 1H-MRS metabolic features could help in predicting the grade of gliomas. The machine-learning model achieved a better prediction performance in grading gliomas than individual features, indicating that it could complement the traditionally used metabolic features.

[1]  W P Dillon,et al.  Preoperative proton MR spectroscopic imaging of brain tumors: correlation with histopathologic analysis of resection specimens. , 2001, AJNR. American journal of neuroradiology.

[2]  Bruce R. Rosen,et al.  Early changes in glioblastoma metabolism measured by MR spectroscopic imaging during combination of anti-angiogenic cediranib and chemoradiation therapy are associated with survival , 2017, npj Precision Oncology.

[3]  A Moreno,et al.  Evidence that mobile lipids detected in rat brain glioma by 1H nuclear magnetic resonance correspond to lipid droplets. , 1997, Cancer research.

[4]  B. Rosen,et al.  Advanced magnetic resonance imaging of the physical processes in human glioblastoma. , 2014, Cancer research.

[5]  Ian C. P. Smith,et al.  1H MRS of high grade astrocytomas: Mobile lipid accumulation in necrotic tissue , 1994, NMR in biomedicine.

[6]  P. Desmond,et al.  Preoperative magnetic resonance spectroscopy improves diagnostic accuracy in a series of neurosurgical dilemmas , 2013, British journal of neurosurgery.

[7]  T. Ryken,et al.  Can tumor contrast enhancement be used as a criterion for differentiating tumor grades of oligodendrogliomas? , 2005, AJNR. American journal of neuroradiology.

[8]  Yu Wang,et al.  CGCG clinical practice guidelines for the management of adult diffuse gliomas. , 2016, Cancer letters.

[9]  Steven J. M. Jones,et al.  Molecular Profiling Reveals Biologically Discrete Subsets and Pathways of Progression in Diffuse Glioma , 2016, Cell.

[10]  Wenzhen Zhu,et al.  Radiomics based on multicontrast MRI can precisely differentiate among glioma subtypes and predict tumour-proliferative behaviour , 2018, European Radiology.

[11]  Mitchel S Berger,et al.  Correlation of magnetic resonance spectroscopic and growth characteristics within Grades II and III gliomas. , 2007, Journal of neurosurgery.

[12]  A. Bjørnerud,et al.  Glioma grading by using histogram analysis of blood volume heterogeneity from MR-derived cerebral blood volume maps. , 2008, Radiology.

[13]  Hui Zhang,et al.  The diagnostic performance of magnetic resonance spectroscopy in differentiating high-from low-grade gliomas: A systematic review and meta-analysis , 2016, European Radiology.

[14]  Patrick Y Wen,et al.  Application of Novel Response/Progression Measures for Surgically Delivered Therapies for Gliomas: Response Assessment in Neuro-Oncology (RANO) Working Group , 2012, Neurosurgery.

[15]  Jean-Marc Constans,et al.  Convex-Envelope Based Automated Quantitative Approach to Multi-Voxel 1H-MRS Applied to Brain Tumor Analysis , 2015, PloS one.

[16]  D. Borsook,et al.  The role of imaging , 2014, Journal of the peripheral nervous system : JPNS.

[17]  Lothar R Schad,et al.  Machine learning in preoperative glioma MRI: Survival associations by perfusion‐based support vector machine outperforms traditional MRI , 2014, Journal of magnetic resonance imaging : JMRI.

[18]  A. Škoch,et al.  Potential of MR spectroscopy for assessment of glioma grading , 2013, Clinical Neurology and Neurosurgery.

[19]  Timothy F Cloughesy,et al.  Emerging Approaches for Targeting Metabolic Vulnerabilities in Malignant Glioma , 2016, Current Neurology and Neuroscience Reports.

[20]  K. Hara,et al.  Noninvasive evaluation of malignancy of brain tumors with proton MR spectroscopy. , 1996, AJNR. American journal of neuroradiology.

[21]  Yuji Akiyama,et al.  Magnetic resonance spectroscopic detection of lactate is predictive of a poor prognosis in patients with diffuse intrinsic pontine glioma. , 2011, Neuro-oncology.

[22]  L. Schad,et al.  A generic support vector machine model for preoperative glioma survival associations. , 2015, Radiology.

[23]  Steven N. Kalkanis,et al.  The role of radiotherapy in the management of patients with diffuse low grade glioma: A systematic review and evidence-based clinical practice guideline. , 2015 .

[24]  Martin R Prince,et al.  Immediate Allergic Reactions to Gadolinium-based Contrast Agents: A Systematic Review and Meta-Analysis. , 2018, Radiology.

[25]  Steven N. Kalkanis,et al.  The role of imaging in the management of adults with diffuse low grade glioma , 2015, Journal of Neuro-Oncology.

[26]  Seung Hong Choi,et al.  Grading of Cerebral Glioma with Multiparametric MR Imaging and 18F-FDG-PET: Concordance and Accuracy , 2014, European Radiology.

[27]  K-H Chang,et al.  3T 1H-MR spectroscopy in grading of cerebral gliomas: comparison of short and intermediate echo time sequences. , 2006, AJNR. American journal of neuroradiology.

[28]  F A Howe,et al.  The clinical value of proton magnetic resonance spectroscopy in adult brain tumours. , 2007, Clinical radiology.

[29]  G. Reifenberger,et al.  The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary , 2016, Acta Neuropathologica.

[30]  Frank G Zöllner,et al.  Support vector machines in DSC‐based glioma imaging: Suggestions for optimal characterization , 2010, Magnetic resonance in medicine.

[31]  J A Frank,et al.  Mapping of brain tumor metabolites with proton MR spectroscopic imaging: clinical relevance. , 1992, Radiology.

[32]  Christos Davatzikos,et al.  Classification of brain tumor type and grade using MRI texture and shape in a machine learning scheme , 2009, Magnetic resonance in medicine.

[33]  Frank G Zoellner,et al.  Predictive modeling in glioma grading from MR perfusion images using support vector machines , 2008, Magnetic resonance in medicine.

[34]  Corinna Cortes,et al.  Support-Vector Networks , 1995, Machine Learning.

[35]  Benjamin Haibe-Kains,et al.  mRMRe: an R package for parallelized mRMR ensemble feature selection , 2013, Bioinform..